Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 29:17:939-945.
doi: 10.1016/j.csbj.2019.05.010. eCollection 2019.

A Web Tool for Ranking Candidate Drugs Against a Selected Disease Based on a Combination of Functional and Structural Criteria

Affiliations

A Web Tool for Ranking Candidate Drugs Against a Selected Disease Based on a Combination of Functional and Structural Criteria

Evangelos Karatzas et al. Comput Struct Biotechnol J. .

Abstract

Drug repurposing techniques allow existing drugs to be tested against diseases outside their initial spectrum, resulting in reduced cost and eliminating the long time-frames of new drug development. In silico drug repurposing further speeds up the process either by proposing drugs suitable to invert the transcriptomic profile of a disease or by indicating drugs based on their common targets or structural similarity with other drugs with similar mode of action. Such methods usually return a number of potential repurposed drugs that need to be tested against the disease in in vitro, pre-clinical and clinical studies. Thus, it is crucial to have a more sophisticated candidate drug ranking in order to start testing from the most promising chemical substances. As a means to enhance the above decision process, we present CoDReS (Composite Drug Reranking Scoring), a drug (re-)ranking web-based tool, which combines an initial drug ranking (i.e. repurposing score or hypothesis/potentiality score) with a functional score of each drug considered in conjunction with the disease under study as well as with a structural score derived from potential drugability violations. Furthermore, a structural similarity clustering is applied on the considered drugs and a handful of structural exemplars are suggested for further in vitro and in vivo validation. The user is able to filter the results further, through structural similarity examination of the candidate drugs with drugs that have failed against the queried disease where related clinical trials have been carried out. CoDReS is publicly available online at http://bioinformatics.cing.ac.cy/codres.

Keywords: Cheminformatics; Data mining; Drug discovery; Drug ranking.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CoDReS summary figure.
Fig. 2
Fig. 2
CoDReS integration scheme.
Fig. 3
Fig. 3
Input score diagrams are drawn after the user uploads a drug list with their respective scores as returned by any drug repurposing tool.
Fig. 4
Fig. 4
Main CoDReS output matrix.
Fig. 5
Fig. 5
Drug score diagrams for each scoring parameter.
Fig. 6
Fig. 6
Structural similarity of input drugs (rows) to clinically failed drugs of input disease (columns) as found in repoDB.

References

    1. Subramanian A., Narayan R., Corsello S.M., Peck D.D., Natoli T.E. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437–1452. [e1417] - PMC - PubMed
    1. Duan Q., Reid S.P., Clark N.R., Wang Z., Fernandez N.F. L1000CDS 2: LINCS L1000 characteristic direction signatures search engine. NPJ Syst Biol Appl. 2016;2 - PMC - PubMed
    1. Backman T.W., Cao Y., Girke T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 2011;39:W486–W491. - PMC - PubMed
    1. Cao D.-S., Xiao N., Xu Q.-S., Chen A.F. Rcpi: R/Bioconductor package to generate various descriptors of proteins, compounds and their interactions. Bioinformatics. 2014;31:279–281. - PubMed
    1. Cao Y., Charisi A., Cheng L.-C., Jiang T., Girke T. ChemmineR: a compound mining framework for R. Bioinformatics. 2008;24:1733–1734. - PMC - PubMed